pharmaphorum2d
J&J's nipocalimab fast-tracked for Sjogren's disease
Johnson & Johnson's FcRn inhibitor nipocalimab has been awarded fast-track status by the FDA as a treatment for Sjögren's ...
JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's Disease
The FDA bestows a Fast Track designation to Johnson & Johnson's nipocalimab for treating moderate-to-severe Sjogren's disease ...
Johnson & Johnson (NYSE:JNJ) Gains FDA Fast Track For Nipocalimab In Treating Sjogren's Disease
Johnson & Johnson (NYSE:JNJ) experienced an 11% share price increase over the last quarter, coinciding with pivotal ...
Johnson & Johnson says FDA grants Fast Track designation to nipocalimab
Johnson & Johnson announced that the U.S. FDA has granted investigational nipocalimab Fast Track designation for the treatment of adult ...
pharmaphorum9mon
J&J’s nipocalimab raises hope for Sjogren’s patients
Johnson & Johnson’s ‘Swiss army knife’ for autoimmune diseases – FcRn inhibitor nipocalimab – has shown efficacy in Sjogren’s disease (SjD), an autoimmune condition that affects ...
Business Insider24d
Kiniksa to discontinue development of abiprubart in Sjogren’s Disease
Kiniksa (KNSA) plans to discontinue the development of abiprubart in Sjogren’s Disease. The company will explore strategic alternatives for the asset. Kiniksa has exercised its right to ...
Medical Dialogues2d
JnJ Nipocalimab gets USFDA Fast Track designation for Sjogren's disease
House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for ...